Cycloartanes with Anticancer Activity Demonstrate Promising inhibition of the Mrckα and Mrckβ Kinases
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 9
Abstract
Aim: The role of Kinases in cancer onset and progression has made kinases a target for the control of some cancers. Recent discoveries that kinases are most effectively inhibited by small molecules have also resulted in an increased search for small molecule kinase inhibitors. Cycloartanes are small molecules found in many medicinal plants including the Jamaican Ball Moss (Tillandsia recurvata). Recent studies on T. recurvata have demonstrated that it possesses anticancer activity. Cycloartane-3,24,25-triol, an analog of a cycloartane identified in Ball moss was also shown to have inhibitory activity against MRCKα kinase. This study was as such set up to determine the MRCKα/β kinase inhibition activity of other cycloartanes in Ball Moss and their analogs. MRCKα/β kinases has been identified as an important kinase implicated in cancer onset and progression and as such a potential drug target. Methodology: Kinase inhibition activity of 6 cycloartanes was investigated using the ligand-kinase binding assay. The WST-1 reagent assay was also used to determine the antiproliferation activity of the cycloartanes against some prostate and breast cancer cell lines. Results: Cycloart-23-ene-3,25-diol (1), Cycloartane-3,24,25-triol (2), Cycloart-25-ene-3,24-diol (3), 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid (4), 24,25-Dihydroxycycloartan-3-one (5) inhibited the MRCKα kinase with Kd of 0.21 μM, 0.25µM, 0.36 µM, 3.0 µM and 2.1 µM respectively. Hydroxycycloart-23-en-3-one,25, (6) showed no inhibition against the MRCKα kinase. Compounds 1, 3, 4, 5 inhibited the MRCKβ kinase with Kd of 4.7 μM, 1.10 µM, 3.2 µM and 9.8 µM, respectively. Three of the six cycloartanes exhibited antiproliferation activity against two prostate and breast cancer cell lines each. Conclusion: Cycloart-23-ene-3,25-diol (1) showed the most promising activity against the MRCKα/β kinase out of the 6 cycloartanes screened demonstrating an interesting structure activity relationship profile when compared with the other molecules. Cycloart-23-ene-3,25-diol (1) deserves further studies to determine its in vivo activity as well.
Authors and Affiliations
Henry I. C. Lowe, Ngeh J. Toyang, Charah T. Watson, Joseph Bryant
Keywords
Related Articles
- EP ID EP348683
- DOI 10.9734/BJMMR/2014/6877
- Views 54
- Downloads 0
Screening for Vascular Disease in Pulmonary Rehabilitation
Background: Several of the comorbidities and risk factors associated with COPD and other pulmonary disorders are also similar to those for lower extremity peripheral artery disease (PAD) and cerebrovascular disease. The...
Bipronged Inverted Impacted Third Molar-A CBCT Analysis
Bilateral inverted impacted third molar is a very rare incidence. Dearth of dental arch length and space are also considered as the chief cause for tooth impaction. Reviewing the literatures, mandibular third molar was t...
Prevalence and Clinical Pattern of Acute and Chronic Complications in African Diabetic Patients
Aims: The aim of this study was to describe the proportion, pro¬file and clinical pattern of acute and chronic complications associated with diabetes and its potential risk factors. Study Design: This was a retrospective...
Practices, Scope and Determinants of School Health Services in Osun State, Nigeria
Introduction: A healthful school environment is that which embraces the health and safety of learners and other members of the school community. Undergoing pre-school medical examination (PSME) is not only necessary to s...
Prevalence of Iron Deficiency Anemia among Chronic Kidney Disease Patients in Kaveri Delta Region, Tamilnadu, India
Background: Iron deficiency anemia (IDA) is the most common type of anemia. But the incidence of iron deficiency anemia in chronic kidney disease (CKD) has not been well established in Kaveri Delta Region, Tamilnadu, Ind...